Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Johnson and Johnson
McKinsey
AstraZeneca
Dow

Last Updated: October 6, 2022

Details for New Drug Application (NDA): 020882


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


NDA 020882 describes NEURONTIN, which is a drug marketed by Viatris and is included in three NDAs. It is available from two suppliers. There is one patent protecting this drug. Additional details are available on the NEURONTIN profile page.

The generic ingredient in NEURONTIN is gabapentin. There are twenty-nine drug master file entries for this compound. Seventy-four suppliers are listed for this compound. Additional details are available on the gabapentin profile page.
Summary for 020882
Tradename:NEURONTIN
Applicant:Viatris
Ingredient:gabapentin
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020882
Suppliers and Packaging for NDA: 020882
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NEURONTIN gabapentin TABLET;ORAL 020882 NDA Parke-Davis Div of Pfizer Inc 0071-0401 0071-0401-24 100 TABLET, FILM COATED in 1 BOTTLE (0071-0401-24)
NEURONTIN gabapentin TABLET;ORAL 020882 NDA Parke-Davis Div of Pfizer Inc 0071-0513 0071-0513-24 100 TABLET, FILM COATED in 1 BOTTLE (0071-0513-24)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength600MG
Approval Date:Oct 9, 1998TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength800MG
Approval Date:Oct 9, 1998TE:ABRLD:Yes

Expired US Patents for NDA 020882

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Viatris NEURONTIN gabapentin TABLET;ORAL 020882-002 Oct 9, 1998 See Plans and Pricing See Plans and Pricing
Viatris NEURONTIN gabapentin TABLET;ORAL 020882-001 Oct 9, 1998 See Plans and Pricing See Plans and Pricing
Viatris NEURONTIN gabapentin TABLET;ORAL 020882-001 Oct 9, 1998 See Plans and Pricing See Plans and Pricing
Viatris NEURONTIN gabapentin TABLET;ORAL 020882-001 Oct 9, 1998 See Plans and Pricing See Plans and Pricing
Viatris NEURONTIN gabapentin TABLET;ORAL 020882-001 Oct 9, 1998 See Plans and Pricing See Plans and Pricing
Viatris NEURONTIN gabapentin TABLET;ORAL 020882-002 Oct 9, 1998 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
McKesson
Johnson and Johnson
Baxter
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.